Evaluating the Episodic Future Thinking Intervention for Reducing Cigarette Consumption in Cigarette Smokers
Study Details
Study Description
Brief Summary
This clinical trial evaluates the effectiveness of active episodic future thinking (EFT) stimuli for reducing cigarette consumption in cigarette smokers. EFT is an innovative framing method shown to significantly activate brain regions involved in future thinking, planning, and other executive functions. Active EFT stimuli are positive events, unrelated to smoking, that participants anticipate, look forward to, and can vividly imagine happening up to 1 year in the future. Control EFT stimuli are positive past events, unrelated to smoking, that participants can vividly remember happening in the recent past. Active EFT stimuli may help reduce cigarette consumption among cigarette smokers by exposing them to personally relevant future oriented stimuli.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
PRIMARY OBJEECTIVE:
- To evaluate the efficacy of episodic future thinking (EFT) for smoking cessation.
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM I (ACTIVE): Participants receive the active EFT stimulus and use the iCOquit Smokerlyzer carbon monoxide monitor on study.
ARM II (CONTROL): Participants receive the control EFT stimulus and use the iCOquit Smokerlyzer carbon monoxide monitor on study.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Arm 1 (active EFT) Participants receive the active EFT stimulus and use the iCOquit Smokerlyzer carbon monoxide monitor on study. |
Behavioral: Smoking Cessation Intervention
Receive active EFT stimulus
Other Names:
Other: Medical Device Usage and Evaluation
Use iCOquit Smokerlyzer carbon monoxide monitor
|
| Active Comparator: Arm II (control EFT) Participants receive the control EFT stimulus and use the iCOquit Smokerlyzer carbon monoxide monitor on study. |
Behavioral: Smoking Cessation Intervention (control)
Receive control EFT stimulus
Other Names:
Other: Medical Device Usage and Evaluation
Use iCOquit Smokerlyzer carbon monoxide monitor
|
Outcome Measures
Primary Outcome Measures
- Reduction in cigarette consumption [From baseline up to 30 days]
Will be measured by ICOquit Smokerlyzer
Secondary Outcome Measures
- Reduction in delay discounting rate [Up to 30 days]
participants will be guided to imagine the situational and sensory details for each of the stimuli until the vividness scores are ≥ 4 on a scale of 1-5 (1=very low, 5=very high).
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Smoke >= 10 cigarettes daily
-
32 on the Vividness of Visual Imagery Questionnaire (VVIQ)
-
No regular use of other tobacco products
-
In possession of a smartphone with text messaging capabilities
Exclusion Criteria:
-
Unable or unwilling to provide verbal consent
-
Unable or unwilling to provide data to the research team
-
Current use of nicotine replacement therapy, bupropion, or varenicline
-
Use of drugs of abuse in the past 30 days
-
Living in the same household as a participant already enrolled in this study
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Roswell Park Comprehensive Cancer Center | Buffalo | New York | United States | 14263 |
Sponsors and Collaborators
- Roswell Park Cancer Institute
Investigators
- Principal Investigator: Christine Sheffer, Roswell Park
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- I 2684022